BSEOthers30 Jul 2026 · 30 Jul 2026, 11:23 pm
BRSR and BRSR Assurance Report FY 2025-26.
Neogen Chemicals Ltd · 542665
✦ AI SummaryESG
Neogen Chemicals Ltd submitted its Business Responsibility and Sustainability Report (BRSR) and Assurance Report for FY 2025-26, as required by SEBI regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Neogen Chemicals Ltd - 542665 - Business Responsibility and Sustainability Reporting (BRSR)
Attachments (1)
📄pdf
Download →
d86d89e3-eee2-4efb-ade2-a8b32c0ab239.pdf
View document text
July 30, 2026
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services, Listing Department,
Floor 25, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G
Dalal Street, Mumbai 400 001 BKC, Bandra (E), Mumbai – 400051
Scrip Code No: 542665 Company Symbol: NEOGEN
Debt Segment Code: 977028
Sub: Business Responsibility and Sustainability Report and Assurance Report for the financial year
2025-26 (BRSR).
Dear Sir/Madam,
In accordance with the requirement of Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we are submitting herewith the BRSR and BRSR Assurance Report for
the Financial Year 2025-26. The BRSR and BRSR Assurance Report also forms part of our Integrated
Annual Report for the Financial Year 2025-26, submitted to the exchange(s) vide letter dated July 30,
2026.
The aforesaid report is also available on website of the Company https://neogenchem.com/wp-
content/uploads/Neogen-Chemicals_AR26_Final.pdf and https://neogenchem.com/wp-
content/uploads/integrated-annual-report-fy-25-26.pdf
Kindly take the above information on your record.
Yours faithfully,
For Neogen Chemicals Limited
Unnati Kanani
Company Secretary & Compliance Officer
Mem. No: A35131
Encl: A/a
Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300
Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399
CIN No. L24200MH1989PLC050919
Business Responsibility &
Sustainability Report 2025-26
SECTION A: GENERAL DISCLOSURES
I. Details of the listed entity
1. Corporate Identity Number (CIN) of the Listed Entity L24200MH1989PLC050919
2. Name of the Listed Entity Neogen Chemicals Limited
3. Year of incorporation 1989
4. Registered office address Office No.1002, 10th Floor, Dev Corpora Bldg., Opp. Cadbury
Co., Eastern Express Highway, Pokhran Rd. No. 2, Khopat,
Thane (W) 400 601, India
5. Corporate address Office No.1002, 10th Floor, Dev Corpora Bldg., Opp. Cadbury
Co., Eastern Express Highway, Pokhran Rd. No. 2, Khopat,
Thane (W) 400 601, India
6. E-mail investor@neogenchem.com
7. Telephone +91 22 2549 7300
8. Website www.neogenchem.com
9. Financial year for which reporting is being done April 1,2025 to March 31, 2026
10. Name of the Stock Exchange(s) where shares are National Stock Exchange of India Limited (NSE) and BSE
listed Limited (BSE)
11. Paid-up Capital `26,38,16,740 consisting of 2,63,81,674 Equity Shares of a
Face Value of `10 each
12. Name and contact details (telephone, email address) Dr. Harin Kanani - Managing Director
of the person who may be contacted in case of any 022-25497300 investor@neogenchem.com
queries on the BRSR report
13. Reporting boundary - Are the disclosures under Standalone basis - Covering corporate offices at Thane and
this report made on a standalone basis (i.e. only for Vadodara along with operational sites at Mahape, Karakhadi,
the entity) or on a consolidated basis (i.e. for the Patancheru and Dahej.
entity and all the entities which form a part of its
consolidated financial statements, taken together)
14. Name of assurance provider Bureau Veritas (India) Private Limited
15. Type of assurance obtained Reasonable Assurance for BRSR Core KPI’s
II. Products/services
16. Details of business activities (accounting for 90% of the turnover):
Sr. Description of Main Description of Business Activity % of Turnover of
No. Activity the entity
1 Organic chemicals Engaged in manufacturing of Bromine Compounds, Advanced 87.13%
Intermediates and Custom Synthesis & Contract Manufacturing
2 Inorganic chemicals The portfolio includes specialty, inorganic lithium- based chemical 12.87%
products which find applications across multiple industries
166 Integrated Annual Report F.Y. 2025-26
CORPORATE OVERVIEW STATUTORY REPORTS FINANCIAL STATEMENTS
17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover):
Sr. No. Product/Service NIC Code % of total Turnover contributed
1 Organic Chemicals 20119 87.13%
2 Inorganic Chemicals 12.87%
III. Operations
18. Number of locations where plants and/or operations/offices of the entity are situated:
Location Number of plants Number of offices Total
National 4 2 6
International 0 0 0
19. Markets served by the entity:
a. Number of locations
Locations Number
National (No. of States) 17 States and 03 Union Territories
International (No. of Countries) 36 countries
b. What is the contribution of exports as a percentage of the total turnover of the entity?
29.17%
c. A brief on types of customers
N eogen Chemicals Ltd. caters to a diverse range of customers across high-growth industries, including
pharmaceuticals that rely on its high-purity intermediates for manufacturing processes. Engineering firms utilize
the company’s engineering fluids, polymer additives, and construction chemicals for industrial applications.
Agrochemical manufacturers source intermediates and custom-synthesized products for pesticides and crop
protection. The electronics sector benefits from electronic chemicals vital for semiconductor production. Battery
chemical customers, especially in lithium-ion materials for electric vehicles and energy storage, form a fast-
expanding segment driven by sustainability trends. Additionally, aroma chemicals and flavours producers, water
treatment plants, and eco-friendly chemical users leverage specialized formulations like vinyl acetate monomer
(VAM). With custom synthesis and contract manufacturing capabilities, Neogen supplies over 258 products,
boasting exports at 29.17% of turnover to 36 countries.
IV. Employees
20. Details as at the end of Financial Year:
a. Employees and workers (including differently abled):
Sr. Particulars Total (A) Male Female
No. (B) % (B / A) No. (C) % (C / A)
EMPLOYEES
1 Permanent (D)* 392 372 95% 20 5%
2 Other than Permanent (E) 0 0 0 0 0
3 Total employees (D + E) 392 372 95% 20 5%
WORKERS
4 Permanent (F) 288 288 100% 0 0
5 Other than Permanent (G) 309 306 99% 3 1%
6 Total workers (F + G) 597 594 99% 3 1%
Neogen Chemicals Limited 167
b. Differently abled Employees and workers:
Sr. Particulars Total (A) Male Female
No.(B) %(B/A) No.(C) %(C/A)
DIFFERENTLY ABLED EMPLOYEES
1. Permanent(D) NIL
2. Other than Permanent (E)
3. Total employees (D+E)
DIFFERENTLY ABLED WORKERS
4. Permanent(F) NIL
5. Other than Permanent (G)
6. Total workers (F+G)
* Note – The employee count also includes permanent employees from the Koproli warehouse.
21. Participation/Inclusion/Representation of women
Total (A) No. and percentage of Females
No. (B) % (B / A)
Board of Directors 8 1 13%
(Including Managing Director and Whole Time Director)
Key Management Personnel (Including CFO and CS) 2 1 50%
22. Turnover rate for permanent employees and workers
F.Y. 2025-26 F.Y. 2024-25 F.Y. 2023-24
(Turnover rate in (Turnover rate in (Turnover rate in the year
current FY) previous FY) prior to previous FY)
Male Female Total Male Female Total Male Female Total
Permanent Employees 18% 19% 18% 19% 0 18% 26% 11% 25%
Permanent Workers 19% 0 19% 21% 0 21% 29% 0 29%
*Note: The calculation done is on the basis of Average number of persons employed in a category as (Persons employed in the
category at the beginning of FY + Persons employed in the category at the end of FY) /2.
V. Holding, Subsidiary and Associate Companies (including joint ventures)
23. (a) Holding Subsidiary and Associate Companies (including joint ventures)
S. Name of the holding / subsidiary / Indicate whether % of Does the entity indicated
No. associate companies / joint ventures holding/ shares at column A, participate in
(A) Subsidiary/ held by the Business Responsibility
Associate/ Joint listed initiatives of the listed entity?
Venture entity (Yes/No)
1 Dhara Fine Chem Industries Joint Venture 90% No
2 Neogen Ionics Limited Wholly Owned 100% No
Subsidiary
3 Neogen Chemicals Japan Corporation Wholly Owned 100% No
Limited Subsidiary
4 Neogen Morita New Materials Limited Step Down 100% No
Subsid
[Showing first 8,000 characters — download PDF for full document]